MTOR and cervical cancer: The present study showed that PGRN contributed to the malignancy of cervical cancer, and inhibition of mTOR signaling by rapamycin disturbed PGRN-driven cervical cell transformation, proliferation and survival in vitro and tumor formation and growth in vivo.